MDxHealth SA
MDXH
$1.74
-$0.06-3.33%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 70.19M | 63.69M | 45.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 70.19M | 63.69M | 45.65M |
| Cost of Revenue | -- | -- | 26.26M | 25.20M | 20.56M |
| Gross Profit | -- | -- | 43.93M | 38.48M | 25.09M |
| SG&A Expenses | -- | -- | 58.59M | 56.83M | 49.99M |
| Depreciation & Amortization | -- | -- | 8.99M | 7.66M | 1.12M |
| Other Operating Expenses | -- | -- | 461.00K | 886.00K | 802.00K |
| Total Operating Expenses | -- | -- | 97.52M | 94.04M | 81.31M |
| Operating Income | -- | -- | -27.33M | -30.36M | -35.66M |
| Income Before Tax | -- | -- | -43.10M | -44.69M | -47.48M |
| Income Tax Expenses | -- | -- | 1.00K | 128.00K | 0.00 |
| Earnings from Continuing Operations | -- | -- | -43.10 | -44.82 | -47.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -43.10M | -44.82M | -47.48M |
| EBIT | -- | -- | -27.33M | -30.36M | -35.66M |
| EBITDA | -- | -- | -20.47M | -23.52M | -31.23M |
| EPS Basic | -- | -- | -1.70 | -2.09 | -2.81 |
| Normalized Basic EPS | -- | -- | -0.25 | -0.56 | -1.17 |
| EPS Diluted | -- | -- | -1.70 | -2.09 | -2.81 |
| Normalized Diluted EPS | -- | -- | -0.25 | -0.56 | -1.17 |
| Average Basic Shares Outstanding | -- | -- | 102.40M | 90.97M | 69.01M |
| Average Diluted Shares Outstanding | -- | -- | 102.40M | 90.97M | 69.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |